Citi Research cut its rating on Amundi to neutral from buy, citing a sharp re-rating that narrowed the valuation discount to European peers. Amundi shares closed at €79.15, having surged over 20% in three months and nearly 30% since Q3 2025 results. The brokerage noted the stock now trades broadly in line with traditional European asset managers and ahead of the wider diversified financials sector. While the 10.5-11x 2027-2028 earnings multiple is not expensive, Citi deemed it no longer cheap given a subdued headline growth profile. The narrowed discount was the central reason for the downgrade. Citi's target price rose to €84.50, implying a 6.8% share price return, with a total expected return of 12.1% including a 5.4% dividend yield. The brokerage maintains its earnings estimates broadly in line with consensus, forecasting €1.90 billion in 2026 and €1.96 billion in 2027.

Citi's analysis highlights a significant shift in market perception. The recent share surge closed the gap to peers, altering the valuation landscape for the asset manager. While underlying growth in the core business remains solid at a 9% CAGR excluding joint ventures, the expected loss of €86 billion in UniCredit assets acts as a major headwind, slowing headline growth. Citi sees limited catalysts beyond the potential IPO of SBI Fund Management, noting the transaction would be a one-off event with minimal visibility on future M&A or new mandates. The downgrade reflects a broader sector re-rating rather than changes to earnings forecasts.

The move underscores the importance of relative valuation in the asset management sector. Investors now view Amundi as fairly valued relative to peers, removing significant upside potential despite steady underlying performance. The target price increase to €84.50 signals a more cautious outlook, tempering expectations for further share price gains. This re-rating could influence investor positioning ahead of potential catalysts like the SBI IPO.

Quick Fact: Citi raised its target price to €84.50 from €78.10.